SCHEMBL972049

SCHEMBL972049

[CH2]CC#CC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8770065 0.85
SCHEMBL13355 0.82
SCHEMBL7366048 0.78
SCHEMBL270459 0.78
SCHEMBL3985734 0.78
SCHEMBL7367366 0.78
SCHEMBL271929 0.78
SCHEMBL3930823 0.78
SCHEMBL7667 0.78
SCHEMBL8769739 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 341 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009005839-A2 COMPOUNDS AND METHODS OF USE THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICE (US) 2009-01-08 WO claimed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP claimed
WO-2024149093-A1 GLUCOCORTICOID RECEPTOR AGONIST AND CONJUGATE THEREOF 四川科伦博泰生物医药股份有限公司 2024-07-18 WO disclosed
CN-118165031-A Nitrile compound, electrolyte, secondary battery and device 蔚来电池科技(安徽)有限公司 2024-06-11 CN disclosed
WO-2024114523-A1 ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2024-06-06 WO disclosed
WO-2024114318-A1 DRUG LINKER COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2024-06-06 WO disclosed
WO-2024114531-A1 HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2024-06-06 WO disclosed
CN-118105508-A Medicinal linker compound, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-05-31 CN disclosed
US-20240174664-A1 BICYCLIC AMINES AS CDK2 INHIBITORS INCYTE CORPORATION 2024-05-30 US disclosed
CN-118073655-A Electrolyte, secondary battery and device 蔚来电池科技(安徽)有限公司 2024-05-24 CN disclosed
US-11981671-B2 Bicyclic pyrazolyl amines as CDK2 inhibitors INCYTE CORPORATION (US) 2024-05-14 US disclosed
US-4460777-A THROMBOXANE SYNTHETASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1984-07-17 US disclosed
EP-0107618-A1 N-substituted-2-(1-imidazolyl)-indoles CIBA-GEIGY AG (CH) 1984-05-02 EP disclosed
US-4444775-A ENZYME INHIBITORS CIBA-GEIGY CORPORATION (US) 1984-04-24 US disclosed
US-4436746-A CARDIOVASCULAR DISORDERS CIBA-GEIGY CORPORATION (US) 1984-03-13 US disclosed
US-4379912-A TRANSESTERIFICATION CATALYSTS EASTMAN KODAK COMPANY (US) 1983-04-12 US disclosed
EP-0068386-A1 Substituted imidazo(1,5-a)pyridines, process for their preparation and pharmaceutical preparations containing these compounds CIBA-GEIGY AG (CH) 1983-01-05 EP disclosed
US-4234734-A 2,2,6,6-Tetramethylpiperidine derivatives CIBA-GEIGY CORPORATION (US) 1980-11-18 US disclosed
US-4211783-A Hypolipidemic and antiatherosclerotic novel 4-(aralkyl- and heteroarylalkylamino)phenyl compounds AMERICAN CYANAMID COMPANY (US) 1980-07-08 US disclosed
EP-0003663-A2 Amino-substituted phenyl and heteroaryl compounds, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1979-08-22 EP disclosed